Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

No reported Short-term Debt figures are available to summarize.

Short-term Debt history

Currency unavailable · from the balance sheet

No Short-term Debt data reported for this period type.

Short-term Debt vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Short-term Debt for ODTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PTGXProtagonist Therapeutics, Inc.Jun 2026$2.4M USD——0.3%
ANABAnaptysBio, Inc.Mar 2026$2.12M USD——0.6%
ACRSAclaris Therapeutics, Inc.Mar 2026$569K USD——0.3%
SYRESpyre Therapeutics, Inc.Sep 2026$0 USD——0.0%
ORKAOruka Therapeutics, Inc.Sep 2026$0 USD-100.0%+81.8%0.0%
ALMSAlumis Inc. Common StockJun 2026$0 USD——0.0%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€0 EUR——0.0%
IMUXImmunic, Inc.Mar 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-100.0%+81.8%0.0%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.